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Summary
Objective: To investigate the direct effect of prolyl-hydroxyproline (Pro-Hyp) on chondrocytes under in vivo and in vitro conditions in an attempt
to identify Pro-Hyp as the bioactive peptide in collagen hydrolysate (CH).
Methods: The in vivo effects of CH and Pro-Hyp intake on articular cartilage were studied by microscopic examination of sections of dissected
articular cartilage from treated C57BL/6J mice. In this study, mice that were fed diets containing excess phosphorus were used as an in vivo
model. This mouse line showed loss of chondrocytes and reduced thickness of articular cartilage, with abnormality of the subchondral bone.
The in vitro effects of CH, Pro-Hyp, amino acids and other peptides on proliferation, differentiation, glycosaminoglycan content and mineraliza-
tion of chondrocytes were determined by MTT activity and staining with alkaline phosphatase, alcian blue and alizarin red. Expression of chon-
drogenesis-speciﬁc genes in ATDC5 cells was determined by semiquantitative Reverse Transcription Polymerase Chain Reaction (RT-PCR).
Results: In vivo, CH and Pro-Hyp inhibited the loss of chondrocytes and thinning of the articular cartilage layer caused by phosphorus-induced
degradation. In the in vitro study, CH and Pro-Hyp did not affect chondrocyte proliferation but inhibited their differentiation into mineralized
chondrocytes. A combination of amino acids such as proline, hydroxyproline and prolyl-hydroxyprolyleglycine did not affect chondrocyte pro-
liferation or differentiation. Moreover, CH and Pro-Hyp caused two and threefold increases, respectively, in the staining area of glycosamino-
glycan in the extracellular matrix of ATDC5 cells. RT-PCR indicated that Pro-Hyp increased the aggrecan mRNA level approximately twofold
and decreased the Runx1 and osteocalcin mRNA levels by two-thirds and one-tenth, respectively.
Conclusion: Pro-Hyp is the ﬁrst bioactive edible peptide derived from CH to be shown to affect chondrocyte differentiation under pathological
conditions.
ª 2009 Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.
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Collagen hydrolysate (CH), a heterogeneous mixture of oligo-
peptides and polypeptides similar to gelatin, has been used
therapeutically as a dietary supplement to improve conditions
of joints. Some animal experiments have suggested that oral
ingestionofCHmight havebeneﬁcial effectson joint conditions
such as osteoarthritis (OA)1,2. CH is absorbed in its high-mo-
lecular-weight form, containing peptides of 2.5e15 kDa3. A
recent study reported detection of peptides such as prolyl
proline (Pro-Pro), alanyl hydroxypropyl glycine (Ala-Hyp-Gly),
prolyl-hydroxyproline (Pro-Hyp), prolyl hydroxypropyl glycine
(Pro-Hyp-Gly), isoleucyl hydroxyproline (Ile-Hyp), leucyl
hydroxyproline (Leu-Hyp) and phenylalanyl hydroxyproline
(Phe-Hyp) in human venous blood after ingestion of CH. Pro-
Hyp was the most prevalent among those peptides4,5.
Many reports indicate that various peptides obtained from
CH show biological activity. For example, the AspeGlye
GlueAla tetrapeptide regulated the expression of osteoblast-
related genes in the bone marrow6. Furthermore, the Pro-
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1620aggregation7.Correspondingly, ahydrogel containingpeptides
from collagen has been used as a scaffold for a true cartilage-
like extracellular matrix in regenerative medicine for effective
and lasting repair of articular cartilage8. These ﬁndings suggest
that some peptides that are metabolites act as bioactive pep-
tides and functional molecules in some tissues, and that CH
contains bioactive peptides that affect cartilage homeostasis.
This study aimed to examine the protective effect of CH
and its speciﬁc dipeptide, Pro-Hyp, in relation to primary de-
generative articular cartilage of mice.Materials and methodsCH, AMINO ACIDS, AND PEPTIDESEnzymatic CH of porcine skin gelatin (01-JP) was a kind gift from Nitta Gelatin
(Osaka, Japan). This hydrolysatewas of food grade and is commercially available.
CH was a mixture of peptides of various molecular weights (average molecular
weightof5000 Da), includingdipeptidesand tripeptides.Gly,ProandHypwerepur-
chased from Sigma Aldrich (Tokyo, Japan). The peptides Pro-Hyp and GlyePro-
Hyp were purchased from PH Japan (Hiroshima, Japan) and used at 95% purity.ANIMALSTen-week-old male C57BL/6J mice were purchased from Clea Japan
(Tokyo, Japan). All the diets used in in vivo experiments were modiﬁcations
of the AIN-93G composition, and we referred to the methods of Morishita
et al.9. The diet compositions are shown in Table I. Potassium dihydrogen
Table I
Compositions of experimental diets
g/kg Diet High Pi diet
N C CH Pro-Hyp
Casein* 200 150 150 150
Lard* 58.3 58.3 58.3 58.3
Corn oil* 11.7 11.7 11.7 11.7
Mineral mixture* 35 35 35 35
Vitamin mixture* 10 10 10 10
Sucrosey 100 100 100 100
Cornstarch* 472.95 472.95 472.95 472.95
Cellulose* 50 50 50 50
KH2PO4y e 59.05 59.05 59.05
L-cystine* 3 3 3 3
Gluteny e 50 e 47
CHz e e 50 e
Pro-Hypx e e e 3
*Oriental yeast (Chiba, Japan), AIN-93G was used as a vitamin
and mineral mixture composition.
yWAKO (Tokyo, Japan).
zNitta gelatin (Osaka, Japan).
xPH JAPAN (Hiroshima, Japan).
1621Osteoarthritis and Cartilage Vol. 17, No. 12phosphate anhydrous (KH2PO4) was used as the Pi source and added in-
stead of cornstarch. Gluten, CH or Pro-Hyp was added instead of casein.
Gluten hydrolysate from corn (Sigma Aldrich) was used as the negative con-
trol. CH contained approximately 6% Pro-Hyp. The mice were randomly as-
signed to four groups of six mice each: a normal (N) group fed a standard diet
containing 0.2 g Pi/100 g; a control (gluten) group fed a diet containing 1.2 g
Pi and 5 g gluten/100 g; a CH group fed a diet containing 1.2 g Pi and 5 g por-
cine skin gelatin/100 g; and a Pro-Hyp group fed a diet containing 1.2 g Pi
and 0.3 g Pro-Hyp/100 g. The mice were allowed free access to food and wa-
ter during the 3-week feeding period. Blood samples were drawn by cardiac
puncture of anesthetized mice. The blood samples were stood for 1 h at room
temperature and centrifuged at 2000 g for 15 min. The resulting supernatants
were employed as serum samples, which were stored at20C until use. Se-
rum inorganic P and Ca were measured with Phospher C test WAKO and
Calcium E test WAKO, respectively (Wako Pure Chemical, Osaka, Japan).
The animals were housed under conditions of constant temperature
(20e22C) and humidity (45e50%), and a standard 12-h light/dark cycle.
The study was performed in accordance with the National Institutes of Health
(NIH) institutional guidelines for the Care and Use of Laboratory Animals. The
experimental protocol was approved by the Institutional Laboratory Animal
Care and Use Committee of The University of Josai, Saitama, Japan.HISTOLOGICAL COMPARISONDissected articular cartilage was immediately immersion-ﬁxed overnight
in a solution of 4% paraformaldehyde in phosphate-buffered saline (PBS),
pH 7.2, at 4C. Articular cartilage sections were cut at a thickness of
10 mm at 22C with a cryomicrotome (Leica, CM3050S) and stained with
Mayer’s hematoxylin (H). Each section was compared at the same thickness
by measuring instrument of cryomicrotome. Articular cartilages of the same
thickness were compared. Each section was observed at 400 or 200
magniﬁcation, and the shape of chondrocytes, distribution of chondrocytes,
thickness of articular cartilage and morphology of subchondral bone were
compared. Apoptosis was assessed using an In Situ Cell Death DetectionTable I
Primers and PCR
Primer Sequence
Runx1 (upstream) 50-acttcctctgctccgtgcta-30
Runx1 (downstream) 50-ggtagcgagattcaacgacc-3
Aggrecan (upstream) 50-cacgctacaccctggactttg-30
Aggrecan (downstream) 50-ccatctcctcagcgaagcagt-3
PEPT1 (upstream) 50-gcgaggtggtcttctctgtc-30
PEPT1 (downstream) 50-cagaagcaatgaggcaaaca-
PEPT2 (upstream) 50-tgtcctggttacagcagcag-30
PEPT2 (downstream) 50-caaaacgaattcagcccact-30Kit (Roche Applied Science) and by observation using the 40,6-diamino-2-
phenylindole (DAPI) ﬂuorescence method.MICRO-COMPUTED TOMOGRAPHY (CT)All measurements were performed with a micro-CT desktop system,
which is based on a combination of X-ray projection microscopy and a tomo-
graphic reconstruction technique (Skyscan 1172, Belgium). In this system,
an air-cooled point X-ray source (focal spot size w8 mm in diameter, maxi-
mum voltage 80 kV) was used to illuminate the object with a divergent
beam. All samples and phantoms were scanned under identical conditions.
Scanning parameters were as follows: anode voltage, 80 kV; rotation step,
0.5; and exposure time, 7 s per view. After scanning, virtual cross-sections
through the bone were reconstructed with a 32-bit dynamic range and con-
verted into 8-bit map images according to the selected density window using
CT-analyzer software.CELLS AND CULTURE CONDITIONSATDC5 cells, a murine chondrocytic cell line, were prepared as described
previously10. Brieﬂy, the basic medium consisted of dulbecco’s modiﬁed ea-
gle medium (DMEM)/F12 medium (Invitrogen) containing 1 mM phosphorus,
0.25 mM glycine and 0.15 mM proline. Hydroxyproline was not included in
the basic medium. Peptone, a pancreatic digest of casein purchased from
BectoneDickinson, was used as a negative control of CH in the in vitro
study. In the experiments, the ATDC5 cells were cultured in four different me-
dia: the basic medium, and the basic medium supplemented with 1 mg/ml
peptone (Pe), 1 mg/ml CH or 2.5 mM Pro-Hyp. Methyl-thiazol-tetrazolium
(MTT) assay was performed after 1 day of culture, alkaline phosphatase
(ALP) staining was performed after 5 days of culture, and alcian blue (AB)
staining and alizarin red (AR) staining were performed after 35 days of cul-
ture. In addition, amino acids such as proline, hydroxyproline, and/or glycine,
dipeptides or tripeptides were added to the basic culture medium to a ﬁnal
concentration of 2.5 mM before the MTT assay on day 1 of culture and
ALP staining on day 5 of culture.RNA EXTRACTION AND RT-PCRATDC5 cells were cultured in 6-cm dishes by seeding at approximately
5 105 cells per dish. After culturing for 1 day, the medium was replaced
by one of four media: basic medium, 1.25 mM proline and 1.25 mM hydrox-
yproline (Pro and Hyp), 2.5 mM Pro-Hyp or 2.5 mM Pro-HypeGly. The cells
in each of these media were cultured for 3, 24 or 72 h, and then the total RNA
was extracted with TRIzol for use in RT-PCR. The method for RNA extraction
and the conditions for RT-PCR for type II collagen (Col2), osteocalcin (OCL),
Smad2, Smad4 and Runx2 were as described previously10,11. The primer
sequences are shown in Table II.STATISTICAL ANALYSISThe results are expressed as the mean standard deviation (SD). In vivo
experiments were carried out n¼ 6 animals each groups. Welch’s t test was
used to identify the ‘number of cells’ and ‘thickness of cartilage’ differences
between control group and Pro-Hyp group. In vitro experiments were carried
out using ﬁve wells for each medium. Each experiment was repeated three
times, and representative results are shown. Multiple comparison of mean
values was performed by Dunnett’s t test. The P value refers to comparison
of a measured parameter in a test medium with that in the basic medium.
Statistical signiﬁcance was set at alpha¼ 0.05 for one-side test. All statistical
computations were performed using SAS version 9.1.3 (SAS Institution,
Cary, NC).I
conditions
Annealing ((C) Cycles
58 28
0
58 28
0
58 30
30
58 30
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HISTOLOGICAL CHANGES IN PHOSPHORUS-INDUCED
CARTILAGE DEGRADATION IN MICEWe examined whether CH and Pro-Hyp affected the artic-
ular cartilage of mice in vivo. In this study, mice that were
fed diets containing excess phosphorus (C) were used as
controls (Fig. 1). The ﬁnal weights and bone lengths of
mice were not signiﬁcantly different among the four groups
(data not shown), and neither were the serum inorganic P
and Ca levels (Table III). Representative histological sec-
tions are shown in Fig. 1(A). Normal integrity of the articular
cartilage was observed in the normal (N) group. Micro-
scopic observation revealed that excess phosphorus
caused a decrease in small chondrocytes on the articular
cartilage surface. Moreover, excess phosphorus induced
loss of cells in the middle layer of the articular cartilage.
Figure 1(F) shows the number of cell for each 250 mm2 on
a section of articular cartilage in each sample. Figure 1(B)
and (E) shows that the thickness of the articular cartilage
layer was decreased slightly by excess phosphorus. The
thickness of the articular cartilage was reduced in the C
group compared to that in the N group. The relative thick-
ness of the articular cartilage of the CH and Pro-Hyp groups
increased to approximately 1.3 times that of the C group
[Fig. 1(B)]. At the same time, histological observation and
micro-CT analysis showed that the subchondral bone was
reduced in thickness and bone mass by excess phosphorus
[Fig. 1(B)e(D)]. In particular, the edge of subchondral bone
was eroded in response to excess phosphorus, and an ab-
normal shape was observed for the cartilage after it lost its
support base [Fig. 1(B) and (D) arrows]. In contrast, CH and
Pro-Hyp mitigated the phosphorus-induced effects. Taken
together, CH and Pro-Hyp ameliorated the reduction of
chondrocytes and subchondral bone [Fig. 1(A)e(D)]. More-
over, with CH and Pro-Hyp, numerous round chondrocytes
were observed compared with N [Fig. 1(A)]. In this study,
apoptosis was not observed in the sections prepared at 3
weeks, either by TdT-mediated dUTP-biotin nick end label-
ing (TUNEL) analysis or the DAPI method in this high-phos-
phorus model (data not shown).CH REGULATES ATDC5 CELL DIFFERENTIATIONNext, we analyzed whether CH and Pro-Hyp affect the
proliferation, maturation and differentiation of ATDC5 cells.
The proliferation of pre-chondrocytes was quantiﬁed by the
MTT assay [Fig. 2(B)] and Mayer’s hematoxylin (H) staining
on day 1 of culture [Fig. 2(A) upper photos]. Metabolic activ-
ity of the CH- or Pro-Hyp-supplemented cells was approxi-
mately equal to the activity of the negative control cells in
the peptone (Pe)-supplemented medium. The staining
areas of glycosaminoglycan were compared by AB staining
at pH 1.0. After 35 days of culture, ATDC5 cells showed an
approximately 1.6 times (P¼ 0.03) greater staining area of
glycosaminoglycan in CH and approximately 2.3 times
(P¼ 0.002) greater staining area of glycosaminoglycan in
Pro-Hyp compared with in Pe medium [Fig. 2(A) middle up-
per photos and (C)]. Cells that had differentiated into hyper-
trophic chondrocytes were quantiﬁed by measuring the ALP
activity by ALP staining on day 5 of culture [Fig. 2(A) middle
lower photos, and (D)]. Moreover, mineralization was quan-
tiﬁed by measuring calcium deposits by AR staining on day
35 of culture [Fig. 2(A) lower photos and (E)]. The ALP ac-
tivity and positive areas seen in AR staining of Pe-supple-
mented cells as a negative control were approximatelyequal to those in the normal (N) group. The ALP activity
and positive areas seen in AR staining of CH- or Pro-Hyp-
supplemented cells were less than half of those in Pe-sup-
plemented cells (P¼ 0.001 and P< 0.0001). These results
indicate that CH contains a bioactive peptide that sup-
presses the differentiation of ATDC5 cells into hypertrophic
chondrocytes and maintain mature chondrocytes that de-
posit aggrecan in the extracellular matrix.IDENTIFICATION OF THE BIOACTIVE PEPTIDE THAT AFFECTS
ATDC5 CELL DIFFERENTIATIONATDC5 cells were cultured in the basicmedium and also in
media prepared by supplementing the basic medium with
2.5 mM of either proline (Pro), hydroxyproline (Hyp), glycine
(Gly), proline and hydroxyproline (Pro and Hyp), proline, hy-
droxyproline and glycine (Pro and Hyp and Gly), Pro-Hyp or
prolyl-hydroxyprolyleglycine (Pro-HypeGly). The cells were
stained with Mayer’s hematoxylin and examined by MTT as-
say on day 1 of culture [Fig. 3(A) upper photo, (B)]. As a result
of microscopic observation, the morphology of the cells was
not changed by Pro, Hyp, Gly, Pro-Hyp or Pro-HypeGly, and
none of these affected proliferation of the cells as shown by
MTT assay. Next, the cells were stained for ALP on day 5 of
culture [Fig. 3(A) lower photo]. None of the amino acid or
peptide supplementations with Gly, Pro, Hyp, Pro and Hyp,
Pro and Hyp and Gly, or Pro-HypeGly affected the ALP-
stained area of the cultured cells compared to the N group.
The ALP activity was decreased only by Pro-Hyp, and the
ALP-stained area of ATDC5 cells cultured in the Pro-Hyp-
containing medium was one-ﬁfth that of the cells cultured
in the basic medium [P< 0.0001; Fig. 3(C)].
Next, we studied whether the concentration of Pro-Hyp in
the medium correlates inversely with the ALP activity of
ATDC5 cells. The ATDC5 cells were cultured in media con-
taining 0, 0.1, 0.5, 1, 2.5, 5 or 10 mM Pro-Hyp for 5 days
and then subjected to ALP staining [Fig. 4(A) lower photo].
The ALP activity of ATDC5 cells cultured in 1, 2.5 and
10 mM Pro-Hyp was approximately two-thirds, one-ﬁfth,
and one-tenth of that of cells cultured in the basic medium
(0 mM Pro-Hyp), respectively [Fig. 4(C)]. That is, increasing
the concentration of Pro-Hyp in the culture medium reduced
theALPactivity of ATDC5 cells in a concentration-dependent
manner. These concentrations, however, did not affect
ATDC5 cell proliferation as determined by the MTT assay
andMayer’s hematoxylin staining [Fig. 4(A) upper photo, (B)].THE mRNA LEVELS OF CHONDROCYTE-ASSOCIATED GENES
AND PEPTIDE TRANSPORTER GENE IN ATDC5 CELLSWe studied whether Pro-Hyp affects chondrogenesis-spe-
ciﬁc gene expression. The total RNA was extracted 24 h after
addition of Pro and Hyp, Pro-Hyp or Pro-HypeGly to the basic
medium, and the mRNA levels were measured by RT-PCR
[Fig. 5(A)]. Compared to the N group, the cells cultured in the
mediumcontainingPro-Hypexhibited approximately two-thirds
(P¼ 0.001) and one-tenth (P< 0.0001) decreases in Runx1
and OCL mRNA levels, respectively [Fig. 5(B)]. On the other
hand,cellscultured in themediumcontainingPro-Hypexhibited
an approximately twofold increase in the aggrecanmRNA level
[P¼ 0.004; Fig. 5(B)]. The Runx2, Smad2 and Smad4 mRNA
levels were not affected by Pro-Hyp. Next, we conﬁrmed
whether mRNA of peptide transporter was expressed to
ATDC5 cells. PEPT1 mRNA expression was detected by RT-
PCR, but it was not affected by ProþHyp, Pro-Hyp or Pro-Hy-
peGly. Conversely, PEPT2 mRNA could not be detected in
ATDC5 cells by RT-PCR (data not shown).
Fig. 1. CH and Pro-Hyp ameliorated the degradation of knee joints in male C57BL/6J mice with phosphorus-induced cartilage degradation.
(A) Photograph of high magniﬁcation (400) of histological sections of articular cartilage from the tibial side of the knee. (B) Whole image
of histological sections of articular cartilage from the tibial side of the knee (200). (C) Subchondral bone images prepared by micro-CT anal-
ysis. (D) Virtual cross-sections through the bone were reconstructed according to the selected density window using the CT-analyzer software.
(E) The thickness of articular cartilage is indicated in the bar graph. The thickness of the articular cartilage was measured at ﬁve ﬁxed positions
in each mouse. (F) The number of cohndrocyte on sections of articular cartilage is indicated in the bar graph. The number of cohndrocyte was
measured at four ﬁxed positions in each mouse. N, C, CH and Pro-Hyp indicate mice that were fed a standard diet, 1.5% phosphorus and 5%
gluten as a control diet, 1.5% phosphorus and 5% CH derived from porcine skin, and 1.5% phosphorus and 0.3% Pro-Hyp, respectively.
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Nutritional factors are important to the maintenance of
bone and joint health, and a nutritional imbalance combined
with endocrine abnormalities may be involved in thepathogenesis of OA1,12e14. High dietary phosphorus intake
reduces bone strength and caused soft tissue mineraliza-
tion15e17. A defect in klotho gene expression in mice results
in articular cartilage degeneration and osteoporosis18. Re-
striction of dietary phosphorus consumption by klotho mice
Table III
Serum calcium and phosphorus concentrations
High Pi diet
N C CH Pro-Hyp
Calcium (mg/dl) 10.6 1.7 10.2 1.3 9.6 0.6 11.0 2.0
Phosphorus (mg/dl) 8.5 2.4 8.9 2.7 7.5 1.9 7.7 0.8
Values are mean SD; n¼ 6/group.
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Therefore, it has been suggested that excessive intake of
phosphorus accelerates articular cartilage degeneration
due to an imbalance in bone and cartilage metabolism. In
a preliminary study, we performed observations each week
for 4 weeks, and a primary disorder of articular cartilage
was noted after 3 weeks on the high-phosphorus diet. Our
high-phosphorus diet model is characterized by a primary
disorder of articular cartilage due to nutritional imbalance.
There is growing evidence that CH might have beneﬁcial
effects on joint conditions1,2. However, few studies to date
have focused primarily on the effects of treatments on joint
conditions1, and there have been no reports on the mecha-
nism by which CH ameliorates articular cartilage degenera-
tion. Recently, it has been shown that not only amino acids
but also oligopeptides are absorbed by the small intestine.
Moreover, Pro-Hyp, a dipeptide, was identiﬁed as the major
constituent of food-derived CH to be detected in human se-
rum and plasma4. We hypothesized that Pro-Hyp reaches
the articular cartilage and acts as a bioactive peptide, exert-
ing a chondroprotective effect. We studied the effects of CH
on articular cartilage in vivo from the viewpoint that CH con-
tains Pro-Hyp as a bioactive peptide that ameliorates artic-
ular cartilage degeneration.
We predicted that C57BL/6J mice administered CH or
Pro-Hyp would show differences in advanced articularFig. 2. Effects of CH and Pro-Hyp on the maturation, differentiation and min
(H), AB pH 1.0, ALP and AR stainings were performed to investigate wh
tiation and mineralization of ATDC5 cells. (B) The signal intensity of the p
The signal intensity of the AB-stained cultures on day 35 of culture (C), th
cultures on day 35 of culture (E) were determined by densitometry and e
culture in a medium containing 1 mg/ml peptone as the negative control
from porcine skin; and (Pro-Hyp): culture in a medium containing 2.5 mM P
The results are expressed as the mean SD. Comparison of mean valu
cultured in each medium were compared tcartilage degeneration when excess phosphorus is admin-
istered and gluten is used as a negative control. The protein
digestibility-corrected amino acid score (PDCAAS) has
been adopted by Food and Agriculture Organization/ World
Health Organization (FAO/WHO) as the preferred method
for the measurement of the protein value in human nutrition.
Collagen doesn’t contain tryptophan, and PDCAAS of colla-
gen is 0. Gluten shows low PDCAAS value. Therefore, glu-
ten was used for control. Intake of excess phosphorus led to
reduced chondrocyte numbers on articular cartilage and de-
creased density of the cartilage layer and subchondral
bone. The serum phosphorus and calcium concentrations
were not affected by intake of excess phosphorus. CH
and Pro-Hyp suppressed phosphorus-induced degradation
of articular cartilage. Moreover, CH and Pro-Hyp caused
chondrocytes in articular cartilage to become round.
Next, we used ATDC5 cells for a screening assay to deter-
mine the factors that preserve mature chondrocytes. Articu-
lar cartilage is thought to preserve mature chondrocytes,
keeping them from differentiating into mineralized chondro-
cytes. In this study, we used the property of ATDC5 cells
that they differentiate from prechondrogenic cells into miner-
alized chondrocytes. We proposed that the factor that pre-
vents differentiation of ATDC5 cells in the mature
chondrocyte stage in vitro is the same factor that maintains
permanent cartilage in vivo. Addition of phosphorus to the
basic culture medium induced higher mRNA levels for vari-
ous transcription factors in ATDC5 cells19,20. In this study,
we experimented with 1 mM phosphorus in the basic me-
dium, since at that concentration it does not induce mRNA
levels of transcriptional factors that lead to mineralization.
Our in vitro study revealed that CH and Pro-Hyp did not af-
fect ATDC5 cell proliferation, but it remarkably inhibited the
ALP activity and showed a larger positive area in AR staining
compared with peptone. As for CH, there are a lot of ratios of
Pro-Hyp and Pro-HypeGly. Peptone was composed oferalization of chondrocytes (ATDC5 cells). (A) Mayer’s hematoxylin
ether CH and Pro-Hyp affect the proliferation, maturation, differen-
roliferation of the cells on day 1 was determined by the MTT assay.
e ALP-stained cultures on day 5 of culture (D), and the AR-stained
xpressed as bar graphs. (Basic): culture in the basic medium; (Pe):
medium; (CH): culture in a medium containing 1 mg/ml CH derived
ro-Hyp. Experiments were carried out in ﬁve wells for each medium.
es was performed by Dunnett’s t test. Statistical signiﬁcance: cells
o cells cultured in the basic medium.
Fig. 3. Effect of Pro-Hyp on ALP activity of ATDC5 cells. (A) The effects of amino acids and peptides on Mayer’s hematoxylin-stained area (H)
and ALP-stained area. Pro-Hyp and Pro-HypeGly were tested as candidate bioactive peptides. Gly, Pro and Hyp were used as negative con-
trols. Pro and Hyp: addition of both Pro and Hyp to the basic medium; and Pro and Hyp and Gly: addition of Pro, Hyp and Gly to the basic
medium. Each peptide and amino acid was added to the basic medium at 2.5 mM. (B) Graph shows the signal intensity of the MTT assay
when the cells were cultured with each peptide and amino acid. (C) Graph shows the signal intensity of the ALP-stained area when the cells
were cultured with each peptide and amino acid. Experiments were carried out in ﬁve wells for each medium. The results are expressed as the
meanSD. Comparison of mean values was performed by Dunnett’s t test. Statistical signiﬁcance: cells cultured in each medium were com-
pared to cells cultured in the basic medium.
1625Osteoarthritis and Cartilage Vol. 17, No. 12various different peptides without speciﬁc bioactivity, and
thus we used it as a control, avoiding possible effects of spe-
ciﬁc peptides involved. Moreover, CH and Pro-Hyp induced
increased amounts of glycosaminoglycan in the extracellular
matrix. BecausePro-Hyp induced increasedmRNA levels for
aggrecan (Fig. 5), Pro-Hyp might induce chondroitin sulfate.
Inductionof glycosaminoglycan synthesis in response toPro-
Hyp should be conﬁrmed by biochemical methods such as
dithiothreitol (DTT) or 35S incorporation in the future. ALP
activity increases at the stage of prehypertrophic chondro-
cytes. AR staining was used to assess mineralization. Calci-
ﬁcation is principally an effect of aging and may contribute to
the progression of OA21e23. The present data suggest that
CH preserves mature chondrocytes and does not allow their
differentiation into mineralized chondrocytes.
Many reports have shown that some oligopeptides affect
cell function and regulate gene expression in vivo and in vitro.
For example, Pro-HypeGly, Pro-Hyp, etc., stimulate chemo-
tactic activity of ﬁbroblasts, peripheral blood neutrophils and
monocytes24,25. AspeGlyeGlueAla stimulates osteoblast-
related gene expression by bone marrow cells6. These re-
ports suggest that some oligopeptides function as bioactive
peptides and regulate the function of tissue cells in vivo.
The present study found that although such amino acids as
glycine, proline, hydroxyproline and Pro-HypeGly did notaffect the ALP activity, Pro-Hyp alone caused a reduction in
theALPactivity of ATDC5 cells. The basicmedium contained
about 0.25 mM glycine and proline, but no hydroxyproline. It
contained about 1 mM phosphorus, which was not supple-
mented. In Fig. 3, the ﬁnal concentrations of Pro, Hyp and
Gly were each 2.5 mM. Therefore, amino acids such as gly-
cine, proline and hydroxyproline were not bioactive, but it is
surmised that dipeptides such as Pro-Hyp act as bioactive
peptides. This suggests that Pro-Hyp might be absorbed in
the small intestine after oral administration and that circulat-
ing Pro-Hyp might regulate chondrocyte metabolism.
During the process of endochondral ossiﬁcation, Runx1
and Runx2 are coexpressed in limb bud cell condensations
that undergo both cartilage and bone differentiation26e28.
Runx1 mediates the onset of mesenchymal cell differentia-
tion in chondrogenesis29. Another study revealed that the
Runx1 consensus sequence binds to an osteoblast-speciﬁc
complex and transcriptionally activates the OCL gene27. In
our study, Pro-Hyp regulated the mRNA levels for Runx1,
OCL and aggrecan in ATDC5 cells. On the other hand,
such free amino acids and tripeptides such as proline, hy-
droxyproline and Pro-HypeGly did not affect those mRNA
levels. The Hþ/peptide transporter PEPT1 and PEPT2
play a key role in the maintenance of mammalian protein nu-
trition30e32. ATDC5 cells expressed the mRNA of one
Fig. 4. Concentration-dependent changes in the intensity of the ALP-stained area due to Pro-Hyp. (A) The effects on proliferation and differ-
entiation of ATDC5 cells following the increase in Pro-Hyp concentration were determined by Mayer’s hematoxylin staining and ALP staining.
(B) Graph shows the relative signal intensity of the MTT assay of Pro-Hyp. (C) Graph shows the relative signal intensity of the ALP-stained
area at each concentration of Pro-Hyp. Experiments were carried out in ﬁve culture wells. The results are expressed as the meanSD. Com-
parison of mean values was performed by Dunnett’s t test. Statistical signiﬁcance: cells cultured in each medium were compared to cells cul-
tured in the basic medium.
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Fig. 5. Effects of Pro-Hyp on mRNA levels for aggrecan, Runx1, OCL and PEPT1 in ATDC5 cells. RT-PCR shows that the aggrecan, Runx1
and OCL mRNA levels were affected by Pro-Hyp in ATDC5 cells. Graphs shows the band intensities determined using ImageJ software,
which were obtained from at least three different experiments. The signals were normalized against those of glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH) transcripts at 24 h. Experiments were carried out in ﬁve culture wells. The results are expressed as the meanSD.
Comparison of mean values was performed by Dunnett’s t test. Statistical signiﬁcance: cells cultured in each medium were compared to cells
cultured in the basic medium.
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Pro-Hyp is predicted to have a speciﬁc binding site for a re-
ceptor or intracellular protein, by which it regulates a speciﬁc
signaling pathway. Consequently, Pro-Hyp might suppress
the differentiation to mineralized chondrocytes by repres-
sing the mRNA levels for Runx1 and OCL, and enhancing
the mRNA level for aggrecan. In the future it will be impor-
tant to identify the signaling pathway of Pro-Hyp.
Our ﬁndings suggest that the Pro-Hyp dipeptide is an im-
portant factor that regulates chondrocyte differentiation and
plays a role in the maintenance of mature chondrocytes in
permanent cartilage. This regulation mechanism by Pro-
Hyp suggests that it might be recognized by chondrocytes,
leading to reduction in the mRNA level forOCL via regulation
of theRunx1mRNA level and termination of differentiation at
themature chondrocyte stage. Pro-Hyp is present in CH, and
this postulated regulation by Pro-Hyp would seem to explain
the mechanism of the therapeutic effect of CH in improving
joint conditions. It was reported that Pro-Hyp is excreted in
human urine33. For that reason, Pro-Hyp is formed in the
body as a collagen degradation product. This study implies
that the bioactive peptide, Pro-Hyp, is derived not only
from collagen in living tissues but also from dietary supple-
ments such as gelatin, and that it functions in target tissues.
Further studies are necessary to investigate the effects of
CH supplements. Also, understanding the mechanism of
action of CH on chondrocyte differentiation would provide
a rational basis for the development of chondroprotective
therapies for damaged joints.Conﬂict of interest
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